key: cord-0314253-wydigpb2
authors: Panpradist, N.; Kline, E.; Atkinson, R. G.; Roller, M.; Wang, Q.; Hull, I. T.; Kotnik, J. H.; Oreskovic, A.; Bennett, C.; Leon, D.; Lyon, V.; Gilligan-Steinberg, S.; Han, P. D.; Drain, P. K.; Starita, L. M.; Thompson, M. J.; Lutz, B. R.
title: Harmony COVID-19: a ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection
date: 2021-08-13
journal: nan
DOI: 10.1101/2021.08.12.21261875
sha: 4c9bc406e1ca78685d5b1b5921b623ca8bb9f25d
doc_id: 314253
cord_uid: wydigpb2

RNA amplification tests sensitively detect SARS-CoV-2 infection, but their complexity and cost are prohibitive for expanding COVID-19 testing. We developed Harmony COVID-19, a point-of-care test using inexpensive consumables, ready-to-use reagents, and a simple device accommodating up to 4 samples simultaneously. Our ready-to-use, 4-plex reverse-transcription, loop-mediated isothermal amplification (RT-LAMP) can detect down to 0.38 SARS-CoV-2 RNA copies/L and can report in 17 min for high viral load samples (5,000 copies/L). Harmony detected 97% or 83% of contrived samples with [≥]0.5 viral particles/L in nasal matrix or saliva, respectively. Evaluation in clinical nasal specimens in viral transport media (VTM, n=101) showed 100% detection of RNA extracted from specimens with [≥]0.5 SARS-CoV-2 RNA copies/L, with 100% specificity in specimens positive for other respiratory pathogens. VTM is non-ideal for Harmony system, yet extraction-free analysis of VTM specimens (n=29) had 95% success in specimens with [≥]1 RNA copies/L. Usability testing performed first-time by healthcare workers showed 95% accuracy

Ready-to-use reagents 152

Our lyophilized RT-LAMP mixture contains primers, sequence-specific fluorescence 153 probes, IAC DNA template, polymerases, supporting proteins, and co-factors (Fig.  154 3A) and is activated by adding the nasal swab eluate containing additional buffer, 155 salts, and detergent. We initially screened excipient formulations that can 156 preserve enzymatic activity and do not significantly interfere with the primer or probe 157 behaviors. We selected trehalose and mannitol since they have been used as 158 excipients for PCR (11-15) and LAMP (16). We found that mannitol did not 159 drastically impact the Harmony's sensitivity compared to trehalose at the same 160 concentration (Fig. S1 ) and did not require adjusting the reaction temperature to 161 maintain the assay speed. Possibly, this is due to the effect of trehalose on altering 162

primer and probe melting temperatures (17). 163

Using a commercial real-time thermal cycler, lyophilized RT-LAMP detected 3/3 164 replicates of 15 RNA copies/reaction (0.38 copies/µL), and IAC was detected in all 165 negative samples (Fig. 3B) . RT-LAMP amplification of 2 x 10 5 RNA copies/reaction 166 using the dry reagents generated detectable signal in 17 min (Fig. 3C ). We subsequently 167 tested our in-house lyophilized reagents on a larger number of technical replicates of 168 SARS-CoV-2 RNA at 20 copies/reaction (0.5 copies/µL) using multiple batches, and 169 90% (36/40, 95% confidence interval (CI): 76 -97%) were amplified (Fig. 3D) . 170 Medians of time to detection for FAM and TEX 615 signals were 28.6 min (range: 28.0 171 -29.4) and 31.7 min (range: 31.1 -32.7), respectively. Based on these preliminary 172 experiments, our limit of detection (LOD) is 15-20 copies/reaction (0.38 -0.5 173 copies/µL) when analyzing purified, synthetic SARS-CoV-2 RNA. Next, we tested our 174 lyophilized RT-LAMP reactions with simulated nasal matrix (salt, mucin, human 175 DNA) to mimic human nasal samples. We observed a 10-min delay in amplification of 176 both SARS-CoV-2 RNA and IAC DNA (Fig. 3E) , but all targets were detected 177 correctly. Greater interference or other harm to the reaction will further delay IAC 178 amplification; thus, the IAC serves as an indicator of the reaction's function and can 179 prevent reporting false negatives due to interference or damaged reagents. By setting a 180 60-min reaction time, the assay can suffer some delay while still correctly identifying 181 positive samples. Specificity testing against closely related pathogens MERS and 182 SARS-CoV-1 showed no cross-reactivity (Fig. S2) .

Hardware: housing and real-time fluorescence reader device 185

The Harmony system includes a heater/detector device controlled by a dedicated cell 186 phone and plastic housing with a sample setup station (Fig. 4A) . The heater/detector 187 device (Fig. 4B) includes an aluminum heater block with four wells and a spring-188 loaded heated lid to prevent condensation. A proportional integral derivative (PID) 189 feedback loop running on a microcontroller allows recovery of the temperature 190 setpoint within 3-4 min after disturbance from opening the lid (Fig. 4C) . Two LEDs 191 (Fig. 4D ) provide the excitation light by shining down through the top of each sample 192 tube. Fluorescence emission passes through holes drilled on the side of the heater 193 block. Each sample well has an emission filter/photodiode set on each side to detect 194 two emission wavelengths (Fig. 4E) RT-LAMP generates inorganic pyrophosphates (PPi) that precipitate from the 202 solution. The cloudiness created by precipitates has been used as a visual readout 203 signal for LAMP (18), but here the cloudiness scattered light and caused non-specific 204 signals in NTC samples (Fig. 4F , top) when tested on device. Inorganic 205 pyrophosphatase (TiPP) can be added to the LAMP reaction to hydrolyze built-up 206 pyrophosphate, and this combination has been used in other contexts to improve 207 differentiation of LAMP products in melt analysis (19) and indirectly detect LAMP 208 via phosphate ions hydrolyzed by the TiPP (20). In fact, TiPP was advertised for its 209 use for the enhancement of DNA replication (21), mitigating pyrophosphorolysis 210 during DNA synthesis for sequencing (22) . In our context, we added TiPP in the RT-211 LAMP reaction to eliminate scattered signal from pyrophosphate to prevent non-212 specific signal in negative reactions (Fig. 4F, bottom) . Interestingly, this effect was 213 not observed when the reaction was tested in the commercial thermal cycler (BioRad 214 CFX96). This is potentially because the commercial thermal cycler uses bandpass 215 filters for both excitation and emission wavelengths, while our device does not have 216 excitation filters. 217

In addition to the physical effects, we have postulated that PPi accumulation may 218 inhibit LAMP; as PPi forms, magnesium phosphate precipitate, Mg 2+ , will be 219 sequestered from the reaction, potentially impairing polymerase activity and primer 220

hybridization. TiPP addition reduces the turbidity that is indicative of magnesium 221 phosphate precipitate, so it may limit the depletion of reaction components. This has 222

implications for multiplexed LAMP reactions, where concurrent amplification of 223 multiple targets is a desired outcome. This possibility or the specific capability of 224

TiPP to "enhance" LAMP has not yet been evaluated. 225 226

Multi-purpose Android mobile app: instruction, temperature control, and real-227 time analysis of results 228

The phone software provides interactive guidance for setting up the test. It prompts 229 the user to input a sample ID by scanning a barcode, capturing a photo, or typing a 230 sample ID (Fig. 5, A-D) . The software also carries out the closed-loop temperature 231 control for the heater block and lid heater, and it displays the status of the heater block 232 to prompt the user to insert the reaction tubes only after the heater reaches the reaction 233 temperature (Fig. 5E ). During the test run, the screen displays the test status 234 ("analysis in progress") and elapsed time, or it reports any detected errors ("failed 235 run") ( Fig. 5F) . Importantly, the software performs real-time data analysis that detects 236 fluorescence intensity rise above a dynamically and automatically computed 237 background level. Signals from SARS-CoV-2 can appear early in the test, especially 238

for high viral loads, and the real-time analysis allows reporting of positive tests 239 immediately after they are detected (Fig. 5G) . Negative results and IND results are 240

reported at the end of the test run time (Fig. 5H) (Fig. 6A) , Harmony 247 detected all positive samples containing ≥50 SARS-CoV-2 viral particles/rxn, and 248 96% of samples containing ≥20 viral particles/rxn. In human nasal matrix (Fig. 6B ) 249 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted August 13, 2021. ; 6 and human saliva (Fig. 6C) , Harmony detected 97% and 83%, respectively, of 250 samples containing ≥20 viral particles/rxn. Harmony had zero false positives across 251 all sample types. Interestingly, unlike the case of simulated nasal matrix (Fig. 3E) , we 252 did not observe delayed detection time of IAC in human nasal or saliva samples. 253

Detection times (mean ± SD) for IAC amplification in negative samples were 32.9 ± 254 3.8 min for PBS, 35.8 ± 4.8 min for human nasal matrix, and 34.3 ± 11 min for human 255 saliva, respectively (p>0.05; t-test, two-tailed). It is worth noting that in this 256 experiment RT-LAMP reactions were either set up at room temperature (intended 257 protocol for our assay, hollow symbols) or on ice (protocol used by most EUA RT-258 LAMP assays as summarized in Table S1 , solid symbols). Even with a small sample 259 size, we observed relatively delayed reaction and more false negative results when the 260 reaction was set up on ice, especially those near the LoD (i.e., 20 copies/rxn). 261 262

Evaluation of clinical specimens using the Harmony COVID-19 system 263 We first tested the assay for reactivity with SARS-CoV-2 and cross-reactivity with 264 other respiratory pathogens using RNA extracted from infected patient specimens. 265

The retrospective clinical samples had been collected in viral transport medium 266 (VTM), which is not the intended sample type for Harmony, since a POC test uses 267 fresh samples and does not require sample transport. Subsequently, we tested a 268 smaller panel enriched with positive specimens to assess the feasibility of detecting 269 SARS-CoV-2 RNA in VTM specimens without extraction. 270

Clinical VTM specimens were collected from individuals positive for SARS-CoV-2 271 (n = 33) or for other pathogenic respiratory infections (n = 68) and were re-tested by 272

RT-qPCR using CDC primer and probe sequences (23) to measure the SARS-CoV-2 273 viral load and provide the reference test result. Using RT-qPCR with CDC 274 primers/probes, 68 specimens were confirmed to be SARS-CoV-2 negative (Fig. 7A,  275 left), 30 specimens were confirmed to be SARS-CoV-2 positive (Fig. 7A, right) , and 276 three previously positive specimens were only detected by one RT-qPCR assay (either 277 N1 or N2) and classified as inconclusive (INC, Fig. 7A , middle). 278

Specimens were tested in duplicate on Harmony using the ready-to-use reagents ( Fig.  279 7A), amplification curves are arranged from low to high virus concentration as 280 quantified by RT-qPCR assay ( Fig. S8 and Fig. S9 detected all positive specimens with ≥20 copies/reaction (0.5 copies/µL). The clinical 290 panel (Fig. 7A ) included 68 specimens that were SARS-CoV-2 negative but contained 291 other respiratory pathogens including influenza, rhinovirus, and seasonal coronavirus 292 (Fig. 7C) , as determined using OpenArray (a laboratory PCR test with microarray 293 detection) (24). Harmony correctly identified all SARS-CoV-2 negative specimens 294 (Fig. 7A, left) . Fig. 7B summarizes the performance of Harmony on detecting 295 extracted RNA from clinical VTM specimens. 296

Next, we used Harmony to detect SARS-CoV-2 in VTM specimens without RNA 297 extraction. We expected the presence of microbial agents in the VTM to delay 298 amplification and thus we ran the reaction for additional 30 min. Compared to RT-299 7 qPCR, Harmony with 90-min run time detected 18/24 positive specimens in both 300

replicates and 3/24 in one of the replicates. Considering each replicate independently, 301

Harmony detected 78% (32/41) and 95% (39/41) SARS-CoV-2 RNA positive 302 specimens within 60-and 90-min detection time, respectively. Detection time (mean 303 ± SD) of IAC in the negative samples with direct VTM amplification (43.9 ± 6.4 min) 304

was significantly slower than the detection time with extracted RNA (38.5 ± 1.6 min; 305 p=0.03, t-test, two-tailed). Pair-wise comparison among positive SARS-CoV-2 306 specimens ( Fig. 7E ) showed two specimens with significantly different detection 307 time. Even though VTM is not the intended sample type, Harmony detected 95% of 308 SARS-CoV-2 VTM specimens that contained at least 1 copy/µL (Fig. 7F) .

Feasibility testing: sample-to-result system tested by healthcare workers and 311 laboratory personnel 312

To complete the system, we developed a test kit that included all components needed 313

for running a test, including the swab, elution buffer, a fluid transfer device, and a 314 ready-to-use reagent tube. Swabs were pre-loaded with SARS-CoV-2 DNA to serve 315 as a control sample to evaluate performance by HCWs and laboratory personnel 316 (LPs). 317

In the first phase of user testing (Fig. 8A) , we compared the accuracy and 318

reproducibility of two methods for transferring the eluate to the reaction tube when 319 operated by LPs (n = 5) and HCWs (such as nurses, medical students, and dental 320 students; n = 10). The first method ( Fig. 8B and shown-previously in Fig. 1 ) used a 321

unified sampler-dispenser. The second method (Fig. 8C) on contrived SARS-CoV-2 DNA swab samples (Fig. 8) . Using the transfer pipette 329 workflow (Fig. 8E) , the test accuracy was 100% (10/10) for LPs and 95% (19/20) for 330

HCWs. Surprisingly, we found that the HCWs performed better than the LPs when 331 using the unified dispenser system (Fig. 8F) HCWs had 89% accuracy, higher than LPs with 71% accuracy (Z-test, two-tailed, p 335 <0.05), when using the unified dispenser system. 336

This work presents a combination of multi-disciplinary engineering (molecular, 338 mechanical, electrical, software, human interface design) to develop a complete 339 system for SARS-CoV-2 detection at the POC. The system is inexpensive and simple 340 yet has features comparable to laboratory-based tests ( Table 1A) . The assay has high 341 sensitivity and specificity in clinical and contrived specimens, and HCWs 342 successfully performed the workflow with high accuracy. 343

Harmony uses ready-to-use reagents that enable fast and accurate assay setup while 344 maintaining high assay sensitivity and specificity. The lyophilized Harmony assay 345 detected as low as 15 copies/reaction of synthetic SARS-CoV-2 RNA and detected all 346 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted August 13, 2021. ; 8 extracted RNA from clinical specimens at ≥20 copies/reaction with no false positives 347 across all sample types. Harmony chemistry is also robust, enabling detection of 348 contrived samples in human nasal matrix (intended sample type) and saliva without 349 RNA extraction. We found excellent sensitivity when testing samples with ≥20 viral 350 particles in nasal matrix (estimated 500 copies/swab for 1mL elution buffer and 40µL 351 reaction). In saliva samples at the same concentrations (not the intended sample type), 352

Harmony showed moderate sensitivity. Heat treatment of saliva shown to enable 353 detection by RT-PCR (25) would likely improve the sensitivity of Harmony with saliva 354 samples. Regardless, our current level of assay sensitivity would be sufficient to detect 355 SARS-CoV-2 in most nasal specimens (~10 3 to ~10 9 copies/swab) (26) or saliva (~10 4 356 to ~10 8 copies/mL) (27) from infected individuals during the first week after the onset. 357

Harmony's high assay sensitivity and specificity despite its high multiplexity was made 358 possible by multiple modifications to traditional RT-LAMP. We used novel polymerase 359

and probe design that can specifically discriminate between the SARS-CoV-2 from 360 IAC amplification while most RT-LAMP analysis in tube relies on detection of total 361

amplification and split each RT-LAMP reaction to detect only one target/reaction 362 (Table S1) . Multi-target amplification is essential to reduce false negatives in SARS-363

CoV-2 nucleic acid tests as the new variants continue to emerge. 364

In addition to the core assay, our lyophilization process also involves non-traditional 365 modifications. Unlike other lyophilized RT-LAMP (28), our lyophilized reagents are 366 magnesium-free, which prohibits any enzymatic activity that may occur before assay 367

initiation. Our lyophilized RT-LAMP is activated upon the addition of sample which 368 contains magnesium and detergent. Thus, it should be less prone to moisture 369 degradation than magnesium-containing lyophilized RT-LAMP. Secondly, WarmStart enzyme in Harmony assay is inactive at room-temperature and thus 371

prevented activities during the reaction set up and eliminated the need for setting up the 372 reaction on ice as performed in other SARS-CoV-2 LAMP assays (Table S1) . Cold 373 temperature can promote dimer and/or secondary structures of LAMP primers, which 374

we observed as a negative impact on the assay sensitivity and speed. In fact, while 375 setting up Harmony assay for lyophilization, RT-LAMP primers and probes were 376 heated and cooled down passively at room temperature to minimize secondary 377 structures prior to mixing with the other components. Last, we removed water to reduce 378 the final volume of lyophilized reaction to 20µL. This enabled doubling the excipient 379 concentrations in the lyophilized pellet and shortens the lyophilization drying time. 380

When testing samples, the excipients are then diluted by half to 40µL reaction, thus 381

reducing any impact of excipients on the core assay function. We anticipate that these 382 components will be stable up to 30 °C but future experiments will be conducted in the 383 final form of the product for future commercialization efforts. 384

Isothermal amplification, like RT-LAMP in Harmony, is often promoted as ideal for 385 POC testing because it can be carried out using a constant temperature heat source, 386

such as a water bath, heat block, or even more novel sources (chemical heat source, 387 sunlight, body temperature) (29). However, reported tests often have other limitations 388 that may prevent their use in POC testing (Table 1B) . Common limitations include 389 use of frozen reagent stocks that must be thawed and then formulated using laboratory 390 pipettes, manual steps for sample processing that require laboratory skill, or detection 391 steps that rely heavily on user interpretation or analysis by a user's cell phone. 392

Harmony is a complete sample-to-result system that uses ready-to-use reagents for 393 simple 1-minute setup and a dedicated device that reports results without extra post-394 amplification steps or reliance on user interpretation. 395 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted August 13, 2021. ;

9 Some RT-LAMP tests use end-point lateral flow strips for detection (Table S1) , 396 which adds a user step, but more importantly, should not be done at the POC because 397

it exposes the testing site to amplicons that will give false positive results in 398 subsequent tests. Others use in-tube detection by eye (30) sensitive, there is potential to further improve the performance. We ran RT-LAMP at 440 64°C, which is 9°C above the optimal temperature for the RT enzyme. We 441 hypothesize that cooling of the heat block when the lid is open, followed by a few 442 minutes to ramp back up to 64°C, provided an opportunity for the RT enzyme to 443 operate. In contrast, the reaction speed of the temperature-stable TFv1 DNA 444 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261875 doi: medRxiv preprint polymerase in this assay is optimal at higher temperature. Thus, operating the device 445

with an initial 55°C step for optimal RT activity followed by a higher temperature 446 step for fast DNA amplification could increase sensitivity and/or speed. 447

The current design of RT-LAMP assay can be improved to include an IAC that is 448 more representative of the SARS-CoV-2 virus. We currently use a DNA IAC, which 449 has been used in several EUA assays, but the DNA control does not capture the 450 potential failure of the lysis and cDNA conversion processes. RNA at 10 10 copies/µL was stored in nuclease-free water in single-use aliquots. 488 SARS-CoV-2 RNA was prepared and quantified as previously described (35, 36) .

In-house TFv1 polymerase production 491 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted August 13, 2021. binding buffer (10mM sodium phosphate and 30mM NaCl at pH 7). Fractions 540 containing protein were concentrated and buffer exchanged into storage buffer 541 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in and did not have cross-reactivity to MERS and SARS-CoV-1. We used two detection 555 probes, each comprised of a fluorescent probe and its complementary quencher probe. 556

For detection of SARS-CoV-2 RNA amplification, we used FAM labeled detection 557 probe and Iowa Black™ quencher probe. For detection of IAC amplification, we used 558 TEX 615 labeled detection probe and BHQ2 labeled quencher probe. The primer and 559

probe sequences are listed in Table S2 .

Wet RT-LAMP reactions 562

Characterization of polymerases (Fig. 2) and 500 copies/µL IAC DNA were prepared in 20µL aliquots of 0.2mL reagent tubes 587 and lyophilized. Packages were stored in desiccant packets at -20°C until use. 588 589

Harmony RT-LAMP reaction setup 590 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Analytical sensitivity of RT-LAMP assay 601

Analytical sensitivity of lyophilized RT-LAMP was tested using purified RNA (0-602 2x10 6 copies/40µL reaction). We also tested the effect of salt, human DNA, and 603 mucin on amplification of SARS-CoV-2 RNA and IAC DNA using simulated nasal 604 matrix as previously described (39). Usability study 622

The Harmony usability study was approved by the Institutional Review Board at the 623 University of Washington (IRB#: STUDY00010884), and informed consent was 624 provided by participants. HCWs (n = 10), including registered nurses, medical 625 students, and dental students were enrolled in this study over the course of 1 month. 626

All data was collected without identifiers. The primary objective of this study was to 627 determine the accuracy and precision of the two sample transfer methods and test if 628 variation in reproducibility impacted assay performance, and the secondary objective 629 was to gather user input on the feasibility of each protocol. Participants first received 630 an explanation of the test and its intended use, then watched an instructional video 631 narrated by the facilitator to become familiar with the Harmony workflow (Movie S1 632 and Movie S2). After watching the video, participants were given a packet with a 633 unique identifier that contained comprehensive instructions for the study procedures 634 and survey questions. Study procedures were modeled on a coaching methodology 635

(40) to allow natural progression of the procedures and to identify blocking steps in 636 the instructions. The facilitator sat 10 feet from the participant and kept a record of 637 verbal questions and comments from participants but did not provide answers to 638 procedural questions unless the participant could not proceed. 639 640 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261875 doi: medRxiv preprint For part 1, data related to user preference on sample preparation, tube sizes, and their 641 level of confidence in performing each task were collected anonymously as prompts 642

within their study packet. Open-ended questions were extracted for themes in errors 643 or issues and supplemented with comments and observations recorded by the 644 facilitator. Samples were saved with de-identified labels, and after all participants had 645 completed the study facilitators measured volumes in each receiving tube from part 1. 646

The variances of the volume recovered by each method were tested for their equality 647 using F-Test, and the P-value was reported. The means of the recovered volumes 648 transferred by LPs or HCWs were compared using Student's t-test (two-sided), and 649 the p-value was reported. 650 651

For part 2, each participant followed instructions in the packet and on the integrated 652 mobile phone to complete the entire Harmony workflow on four total contrived 653 samples (two samples using the transfer pipette protocol and two using the unified 654 sampler system). Kits were prepared as specified above. 655 656

The lab personnel (n = 5) portion of the user testing aimed to compare performance of 657 the Harmony device by HCW to that of an "experienced" population, by replicating 658 this process with four students and a researcher from the Lutz Lab. Survey questions 659

were omitted for this group because these volunteers provided feedback throughout 660 the development of Harmony and their views are included in the discussion of this 661 manuscript. The accuracies of tests performed by LPs and HCWs using each method 662

were tested for their equality using Z-test (two-sided), and the p-value was reported. 663 664

Clinical nasal swab specimens from individuals presenting respiratory symptoms 665

A minimum sample size of 30 (each negative and positive) was required to achieve 666 the confidence interval (CI) of 90 -100% (binomial cumulative distribution function) 667

should all results be accurate. Our clinical specimen panel (n = 110) was previously 668 used to evaluate other SARS-CoV-2 assays (35), but 9 specimens had insufficient 669 volume for RNA extraction and were thus excluded from the study. These specimens 670

were collected with informed consent as part of the Seattle Flu Study, approved by the 671

Institutional Review Board at the University of Washington (IRB#: STUDY0006181). 672

Thermo Fisher's OpenArray is an arrayed RT-qPCR system capable of detecting up to 673 26 pathogens simultaneously in a semi-quantitative manner. Specimens from the 674 Seattle Flu Study that had other respiratory pathogens detected using the OpenArray 675 platform were used to determine cross reactivity with Harmony. All participant 676 specimens were de-identified prior to the transfer to the Lutz Lab at the University of 677

Washington for analysis. The remaining 101 specimens were evaluated using the 678 newly extracted RNA for analysis by RT-qPCR and Harmony system, to avoid 679 variations introduced from different batches of extraction. RNA was extracted 680 from clinical nasal swab specimens stored in viral transport media using 681

the QIAamp Viral RNA Mini Kit (52906; Qiagen, Hilden, Germany). Prior to 682 extraction, 100µL of each specimen was mixed with 40µL negative VTM to reach the 683 suggested 140µL sample volume. RNA was extracted according to the manufacturer's 684 protocol, eluted into 70µL of EB buffer, and stored at -80°C in single-use aliquots 685 until amplification. 5µL of RNA was used for analysis in 20µL RT-qPCR using U.S. 686 CDC N1, N2, or RP human control assays (23). 10µL of RNA was used for analysis 687 in 40µL lyophilized RT-LAMP in the Harmony workflow. Each sample was run in 688 duplicate. Only samples with positive results from both Harmony replicates were 689

reported as positive for SARS-CoV-2. Sensitivity (TP/(TP + FN)), specificity 690 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted August 13, 2021. ;

(TN/(TN+FP)), and concordance ((TP+TN)/(TP+TN+FP+FN)) were calculated and 691

reported with 95% CI using binomial exact proportions. 692 693 XPRIZE contrived sample panel 694

The blinded panel was assembled and distributed by HudsonAlpha Discovery 695 (Huntsville, AL) for the COVID-19 XPRIZE competition, and information on the 696 samples was revealed to the authors only after results were submitted to XPRIZE. 697

Samples were shipped to the Lutz Lab at the University of Washington. We reported 698 results for contrived samples of chemically inactivated SARS-CoV-2 viral particle 699 (ZeptoMetrix Corporation, Buffalo, NY) spiked in phosphate-buffered saline (1x 700 PBS) (n = 29), nasal specimens (n = 20), or saliva (n = 20) at 0 to 1000 701 copies/reaction. All samples came in liquid form. We added 10µL sample and 30µL 702

Harmony rehydration buffer to rehydrate each lyophilized reagents and tested across 7 703 different Harmony devices. Each sample was originally tested once for each sample. 704

To affirm the identity of these specimens, we also performed RT-qPCR using CDC 705 primer/probes after the samples had been tested using the Harmony system. To 706 improve our confidence in reporting sensitivity and specificity, we tested two 707

additional replicates for each sample to achieve a total of triplicates. 708 709

Housing 710

The housing combines the heater/reader assembly with the cell phone, while 711

concealing the connector cables and presenting a sturdy and easy-to-use platform. The 712

3D CAD program, Fusion 360 (AutoDesk), was used for the design of housing. 713

Prototypes were printed in PLA plastic (Overture™ Filament, OVPLA175 ) using a 714

Prusa i3 MK3s at 0.3mm layer height. Power was supplied to both the heater/reader 715 assembly and the phone simultaneously using a Charge-Plus USB-C (LAVA 716

Computer Manufacturing Inc.) connector device and a standard fast-charging 717

American cellphone charger. The LAVA device also facilitates the transfer of data 718 between the devices. 719 720 721

Reader/heater device 722

The aluminum block to house the reagent tubes was custom-made by Bryan 723

Willman according to the specifications in Fig. S3 . The circuit boards were designed 724

using Autodesk Eagle (San Rafael, CA), and the assembly of the circuit boards are 725 shown in Fig. S4 and Fig. S5 . The lid, latch, and upper and lower housing of the 726 device were drawn using SolidWorks (Dassault Systèmes, Waltham, MA) and printed 727 by Xometry -HP MultiJet Fusion 3D (Gaithersburg, MD). All parts were assembled 728 as shown in Fig. S6 .

Real-time fluorescence signal analysis 731

After the user inserts the reaction tube into the device, the software adjusts the 732 temperature to re-equilibrate the temperature of heat block back to the reaction 733 temperature. During this initial period, the signals from the photo diodes (the blue 734 LED (FAM signal for target amplification) and the yellow LED (TEX 615 signal for 735 the IAC amplification)) are collected but not used in analyses. Once the initial period 736

is over, signal analysis commences. Each signal is analyzed in real time by comparing 737 the current mean of the signal over the most recent 60s interval to the signal's 738 behavior some 360s in the past. Specifically, the current mean is compared to a bound 739

consisting of the signal's mean over the period from 420s to 360s in the past plus a 740 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in using either a unified sampler-dispenser (shown) or a tube-and-bulb method (Fig. 8) .

The swab eluate is then transferred into the reaction tube to rehydrate lyophilized, pre-988 loaded RT-LAMP reagents. Users follow the instructions on the cell phone app to 989 record the sample identity, insert the tube in the test slot, and close the device. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in to RT-qPCR using CDC primers and probes (5µL RNA in 20µL RT-qPCR reaction). 1119

(B) Organisms in clinical samples collected from individuals presenting with 1120 respiratory symptoms were quantified using OpenArray, as previously described(35). 1121

High quantification cycle values indicate low concentrations. All these specimens 1122 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Primers, probes, and control sequences. 1175 Table. S3. 1176

Feedback from the HCWs 1177 Table. S4. 1178

Detailed reagent and device cost at a production scale of 10,000 units. 1179 Table. S5.

Consumable costs per test 1181 1182 Fig. S1 . 1183

Effects of excipients on fresh RT-LAMP reactions tested on a commercial real-time 1184 thermal cycler. 1185 Fig. S2 . 1186

Cross-reactivity of MERS and SARS in lyophilized RT-LAMP. 1187 Fig. S3 .

Heat block used in Harmony COVID-19 device. 1189 Fig. S4 . 1190

The design of optical and heater circuit boards for the Harmony COVID-19 device. 1191 Fig. S5 .

Circuit board assembly and required parts 1193 Real-time amplification curves of RT-qPCR using CDC primers/probes. 1204 1205

Video S1 Demonstration of transfer pipette workflow incorporated with Harmony 1206 COVID-19. 1207

Video S2 Demonstration of the integrated sampling system workflow with Harmony 1208 COVID-19 1209 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted August 13, 2021. ; https://doi.org/10.1101/2021.08.12.21261875 doi: medRxiv preprint

If the current mean exceeds the bound, and maintains that condition 742 for at least 15s, the signal is said to have "indicated". If the signal from the target 743 emission indicates, the presence of SARS-CoV-2 has been detected, and the software 744 immediately reports "positive COVID-19". If the signal from the IAC emission 745 indicates, successful amplification of the IAC has been detected. Then, if the target 746 emission does not also indicate before the end of the run, then a "negative COVID-747 19" result is reported; this delay in reporting negative results provides the maximum 748 opportunity to detect low concentrations of SARS-CoV-2 that may be present in 749 samples

WHO Declares COVID-19 a Pandemic. Acta bio-754 medica

WHO Coronavirus

Coronavirus: Half of humanity now on lockdown as 90 758 countries call for confinement

Economic and social consequences of human mobility 762 restrictions under COVID-19

Postvaccination SARS-CoV-2 Infections Among Skilled 764 Nursing Facility Residents and Staff Members

Requirement for Proof of 773 Negative COVID-19 Test or Recovery from COVID-19 for All Air Passengers 774 Arriving in the United States

Multiplex target-redundant RT-LAMP for robust 778 detection of SARS-CoV-2 using novel fluorescent universal displacement probes

A colorimetric RT-LAMP assay and LAMP-sequencing 781 for detecting SARS-CoV-2 RNA in clinical samples

Colorimetric isothermal nucleic acid detection of SARS-CoV-2 783 with dye combination

Room-temperature-storable PCR mixes for SARS-CoV-2 785 detection

OLA-Simple: A software-guided HIV-1 drug resistance 787 test for low-resource laboratories

Near point-of-care, point-mutation test to detect drug 789 resistance in HIV-1: a validation study in a Mexican cohort

OLA Simple v 1.0: observational study of an app-guided HIV 791 drug resistance test at the Coptic Hope Center

Lyophilized beads containing 793 mannitol

Rapid Detection of Hepatitis B Virus in Blood Plasma by a 796 Specific and Sensitive Loop-Mediated Isothermal Amplification Assay

Economic burden 845 of seasonal influenza in the United States

Simpler and faster Covid-19 testing: Strategies to 848 streamline SARS-CoV-2 molecular assays

Inexpensive workflow to enable simultaneous monitoring of 850 HIV viral load and detection of SARS-CoV-2 infection. medRxiv

Ligation Independent Cloning

Swab sample transfer for point-of-care diagnostics: 855 characterization of swab types and manual agitation methods

Optical Filters

Direct detection of SARS-CoV-2 using non-commercial 866 RT-LAMP reagents on heat-inactivated samples

SARS-CoV-2 detection using isothermal amplification 868 and a rapid, inexpensive protocol for sample inactivation and purification

Direct diagnostic testing of SARS-CoV-2 without the need for 871 prior RNA extraction

Point-of-care bulk testing for SARS-CoV-2 by 873 combining hybridization capture with improved colorimetric LAMP

Development of a point-of-care test to detect SARS-CoV-2 from saliva which 877 combines a simple RNA extraction method with colorimetric reverse transcription 878 loop-mediated isothermal amplification detection

An enhanced isothermal amplification assay for viral detection

Clinical validation of a Cas13-based assay for the 882 detection of SARS-CoV-2 RNA

Point-of-care testing for COVID-19 using SHERLOCK 884 diagnostics. medRxiv

CRISPR-Cas12-based detection of SARS-CoV-2

The left panel shows the average (n 1029 = 3) FAM signal detecting SARS-CoV-2. *Only 2/3 replicates of 10 copies/rxn 1030 amplified so the average was from duplicate reactions. The right panel shows TEX 1031 615 signal detecting the internal amplification control (IAC). The IAC was detected in 1032 the NTC (n = 3) and in the single 10 copies/reaction that did not detect SARS-CoV-2. 1033 (C) Time to detection of SARS-CoV-2 and IAC targets reported by the real-time 1034 thermal cycler. Individual data points are plotted. Note that only 2/3 replicates of 10 1035 copies/reaction amplified. IAC signals were properly detected in NTC (n = 3) and 1 1036 of the 3 replicates of 10 copies/reaction undetected for SARS-CoV-2. (D) Evaluation 1037 of analytical sensitivity at 20 copies/reaction of SARS-CoV-2 RNA (n = 40), 1038 performed in two different runs (n = 20 each) with two different serially diluted RNA 1039 samples. Time-to-result of individual samples are plotted along with medians

SARS-CoV-2 RNA at 0, 40, or 100 copies/reaction (corresponding to 0, 1, or 2.5 1043 copies/µL) was amplified in lyophilized RT-LAMP in the presence of simulated nasal 1044 matrix (n = 3). All data was measured every 13s using FAM and TEX 615 channels, 1045 by a real-time thermal cycler

The heater/reader device contains an aluminum block 1057 with wells for four samples (0.2mL reagent tubes) and is heated from the bottom by a 1058 resistive heater made from serpentine conductive traces on a printed circuit board. In 1059 the middle of the heater, a temperature sensor (Class B Platinum RTD) is used to 1060 measure the heat block temperature. Power to the heater is supplied by a MOSFET 1061 and modulated by varying the PWM duty cycle of the MOSFET. (C) Temperature 1062 profile after the lid opening throughout a 60-min assay run. The microcontroller (die) 1063 is measured to ensure the electronics are not overheated. (D) Lid heater, LED, and 1064 detector. A heater (85°C) on top of the tube prevents condensation on the tube 1065 lid. The lid heater is spring loaded to apply a preload force to the tubes to ensure good 1066 thermal contact and contains pass-through holes for excitation LEDs. (E) Spectral 1067 characteristics of the detection system. Blue and yellow LEDs provide excitation for 1068 FAM and TEX 615, respectively, and photodetectors on each side detect light passing 1069 through emission filters (spectral information from manufacturers(41-43)). The LEDs 1070 are operated independently (only one LED is illuminated at a given time). (F) Effect 1071 of thermostable inorganic pyrophosphatase (TiPP) on RT-LAMP signal in the 1072 Harmony device

Intended use of the device. (B) Instructions for the user to prepare samples. 1082 (B) Selection of the number of samples. (D) Collection of sample identifiers by 1083 barcode, photo capture, or manual typing. (E) Instruction to insert the tube when the 1084 temperature of the device reaches the reaction temperature. (F) Real-time analysis 1085 during the test run. (G) Positive results are reported as soon as they are detected

Analysis of XPRIZE contrived sample panel without RNA extraction. (A) Viral 1091 particles spiked in 1xPBS were tested in triplicate for each sample (n = 9 total for 1092 positive sample concentrations and n = 6 total for negative samples). (B) Viral 1093 particles spiked in human nasal matrix were tested in triplicate (n = 6 total for each 1094 concentration). (C) Viral particles spiked in saliva

Concentrations of viral particles are the 1097 final concentrations in each 40uL reaction. Threshold concentration for positive is at 1098 20 viral particle copies/reaction (0.5 copies/µL)

Without the RNA extraction step, 10µL VTM was added in 1127 the final 40µL RT-LAMP rxn, (n = 2). Dashed line indicates the detection time at 60 1128 min. (E) Bland-Altman plot of the detection time of SARS-CoV-2 positive specimens 1129 of the direct VTM group compared to the extracted RNA group

Summary table for the sensitivity of the Harmony COVID-19 system using VTM 1132 specimens without extraction